Brief: Assembly Biosciences Nominates First Herpesvirus Development Candidate Abi-5366

Assembly Biosciences

15/02/2023 13:51

Feb 15 (Reuters) - Assembly Biosciences Inc  ASMB.O :
    * ASSEMBLY BIOSCIENCES NOMINATES FIRST HERPESVIRUS
DEVELOPMENT
CANDIDATE ABI-5366, A LONG-ACTING HSV-2 HELICASE INHIBITOR
TARGETING HIGH-RECURRENCE GENITAL HERPES

Source text for Eikon:  ID:nGNX40ll7C 
Further company coverage:  ASMB.O 
 ((Reuters.briefs@thomsonreuters.com;))